In these genetically modified mice, possible styrene metabolism by the human CYP2F isoform or that of native CYP2E1 in the CYP2F2-KO mice, also is insufficient to initiate any pre-neoplastic events resulting in potential cancer outcomes. The gene discussed is CYP2E1; the disease is cancer.